Financhill
Sell
49

VRTX Quote, Financials, Valuation and Earnings

Last price:
$484.88
Seasonality move :
12.78%
Day range:
$471.50 - $487.13
52-week range:
$377.85 - $519.88
Dividend yield:
0%
P/E ratio:
26.10x
P/S ratio:
11.60x
P/B ratio:
7.71x
Volume:
1.3M
Avg. volume:
1.4M
1-year change:
15.98%
Market cap:
$126.5B
Revenue:
$11B
EPS (TTM):
-$2.20

VRTX Analysts' Consensus Rating

The 29 analysts providing 12-month price projections for Vertex Pharmaceuticals shares anticipate an average target of $497.01, ranging from a low estimate of $330.00 to a high estimate of $615.00. This average target implies a growth of 0.91% compared to the current stock price of $492.69.

Consensus Price Target

$497.01

Highest Price Target

$615.00

Lowest Price Target

$330.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 15 16 16

Hold 9 11 12

Sell 2 2 1
Consensus Buy Buy Buy

VRTX Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is up 109.21% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.

Buy
74
COOP alert for Apr 1

Mr. Cooper Group [COOP] is up 14.4% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock